As 2023 comes to a close, Eat Move Think is rounding up the health and wellness trends and updates that left lasting impressions on such Medcan experts as Shaun Francis, Dr. Peter Nord, Leslie Beck and Dr. Andrew Miners. How did their own personal wellness evolve? What innovations will they be watching next year? And what are the biggest takeaways that you can carry forward to optimize your own health in 2024?

Last year, Medcan director of weight management Dr. David Macklin (pictured above) predicted the diabetes medication semaglutide would be a game changer for those seeking help to lose weight. So we invited back Dr. Macklin to get his perspective on the medication, now that it’s actually on the market and being used by hundreds of thousands of people across North America. Joined by Medcan CMO Dr. Peter Nord, Dr. Macklin explains semaglutide’s benefits, side effects and costs — and describes what’s different about Medcan’s approach to weight management in the semaglutide era.